Related Experiment Video
Updated: Nov 30, 2025

Establishment of a Rat Model of Superior Sagittal-Sinus Occlusion via a Thread-Embolism Method
Published on: July 4, 2021
Cerebral Venous Sinus Thrombosis in the COVID-19 Pandemic
Chaitanya B Medicherla1, Rachel A Pauley, Adam de Havenon
1Department of Neurology (CM, RAP, SY, KI, JT), New York University Langone Medical Center, New York, New York; and Department of Neurology (AdH), University of Utah School of Medicine, Salt Lake City, Utah.
Insights
Coronavirus Disease 2019 (COVID-19) is linked to an increased risk of cerebral venous sinus thrombosis (CVST), a rare but serious clotting condition. This review details CVST
Area of Science:
- Neurology
- Ophthalmology
- Infectious Diseases
Background:
- Emerging evidence suggests a link between Coronavirus Disease 2019 (COVID-19) and an increased incidence of thromboembolic events.
- Cerebral venous sinus thrombosis (CVST) has been identified as a significant neuro-ophthalmologic complication associated with COVID-19.
Purpose of the Study:
- To provide a comprehensive overview of cerebral venous sinus thrombosis (CVST) in the context of COVID-19.
- To discuss the epidemiology, clinical presentation, diagnostic approaches, pathophysiology, and management strategies for CVST related to COVID-19.
Main Methods:
- Systematic review of the existing scientific literature.
- Analysis of reported cases and studies concerning CVST and COVID-19.
Main Results:
- Cerebral venous sinus thrombosis (CVST) is an infrequent thromboembolic condition with diverse clinical manifestations and etiological factors.
- Neurological sequelae of CVST can be severe, potentially leading to profound visual impairment and mortality.
- The COVID-19 pandemic appears to significantly influence the risk and presentation of CVST.
Conclusions:
- Increased vigilance regarding the presentation, pathogenesis, and management of CVST is warranted due to its association with COVID-19.
- Understanding the interplay between COVID-19 and CVST is crucial for effective patient care and outcomes.
Background:
Recent studies have noted concern for increased thromboembolic events in the setting of Coronavirus Disease 2019 (COVID-19). Cerebral venous sinus thrombosis (CVST) is a form of thromboembolism that has been observed as a neuro-ophthalmologic complication of COVID-19.
Methods:
Review of the scientific literature.
Results:
In this article, we report an overview of CVST epidemiology, clinical presentation, diagnostics, disease pathophysiology, and management in the setting of COVID-19.
Conclusion:
CVST is an uncommon thromboembolic event with variable phenotypes and multiple etiologies. Neurologic complications can be severe, including significant visual deficits and death. Current observations suggest that the risk of CVST may be profoundly impacted by this novel COVID-19 pandemic, thus prompting increased attention to disease presentation, pathogenesis, and management.
More Related Videos
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Venous Thrombosis I: Introduction
Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
Venous Thrombosis IV: Nursing Management
Veins of Head and Neck
On the other hand, the vertebral veins, unlike their arterial counterparts, are not primarily responsible for brain drainage. Instead, they drain the cervical vertebrae, spinal cord, and some small...
Overview of Systemic Veins
The coronary sinus, the heart's principal vein, resides in the coronary sulcus on the heart's posterior aspect. This broad venous channel receives nearly all venous blood from the myocardium, the heart muscle. It is fed by three primary veins: the great cardiac vein, the...

